Exploring clinical factors to predict the survival of patients with resectable non-small cell lung cancer with neoadjuvant immunotherapy.

MLA

Zhang, Mengzhe, et al. “Exploring Clinical Factors to Predict the Survival of Patients with Resectable Non-Small Cell Lung Cancer with Neoadjuvant Immunotherapy.” European Journal of Cardio-Thoracic Surgery, vol. 66, no. 4, Oct. 2024, pp. 1–11. EBSCOhost, https://doi.org/10.1093/ejcts/ezae335.

APA

Zhang, M., Yan, M., Xiao, Z., Li, Y., Liu, Z., Zhang, P., Wang, X., Zhang, L., & Zhang, Z. (2024). Exploring clinical factors to predict the survival of patients with resectable non-small cell lung cancer with neoadjuvant immunotherapy. European Journal of Cardio-Thoracic Surgery, 66(4), 1–11. https://doi.org/10.1093/ejcts/ezae335

Chicago

Zhang, Mengzhe, Meng Yan, Zengtuan Xiao, Yue Li, Zuo Liu, Pengpeng Zhang, Xiaofei Wang, Lianmin Zhang, and Zhenfa Zhang. 2024. “Exploring Clinical Factors to Predict the Survival of Patients with Resectable Non-Small Cell Lung Cancer with Neoadjuvant Immunotherapy.” European Journal of Cardio-Thoracic Surgery 66 (4): 1–11. doi:10.1093/ejcts/ezae335.